AURORA CANNABIS INC (ACB.CA) Stock Price & Overview
TSX:ACB • CA05156X8504
Current stock price
The current stock price of ACB.CA is 4.7 CAD. Today ACB.CA is down by -1.88%. In the past month the price increased by 2.4%. In the past year, price decreased by -25.87%.
ACB.CA Key Statistics
- Market Cap
- 266.537M
- P/E
- N/A
- Fwd P/E
- 58.17
- EPS (TTM)
- -0.91
- Dividend Yield
- N/A
ACB.CA Stock Performance
ACB.CA Stock Chart
ACB.CA Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to ACB.CA. When comparing the yearly performance of all stocks, ACB.CA is a bad performer in the overall market: 95.35% of all stocks are doing better.
ACB.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ACB.CA. The financial health of ACB.CA is average, but there are quite some concerns on its profitability.
ACB.CA Earnings
On February 4, 2026 ACB.CA reported an EPS of 0.03 and a revenue of 94.19M. The company missed EPS expectations (-86.02% surprise) and beat revenue expectations (0.96% surprise).
ACB.CA Forecast & Estimates
10 analysts have analysed ACB.CA and the average price target is 7.17 CAD. This implies a price increase of 52.46% is expected in the next year compared to the current price of 4.7.
For the next year, analysts expect an EPS growth of -2438.15% and a revenue growth 6.2% for ACB.CA
ACB.CA Groups
Sector & Classification
ACB.CA Financial Highlights
Over the last trailing twelve months ACB.CA reported a non-GAAP Earnings per Share(EPS) of -0.91. The EPS decreased by -502.65% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -11.45% | ||
| ROE | -16.55% | ||
| Debt/Equity | 0.06 |
ACB.CA Ownership
ACB.CA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| BHC | BAUSCH HEALTH COS INC | 1.14 | 2.527B | ||
| CRON | CRONOS GROUP INC | 38.86 | 1.304B | ||
| TLRY | TILRAY BRANDS INC | N/A | 1.105B | ||
| DHT-UN | DRI HEALTHCARE TRUST | 7.33 | 923.618M | ||
| GUD | KNIGHT THERAPEUTICS INC | 127.15 | 602.253M | ||
| WEED | CANOPY GROWTH CORP | N/A | 569.809M | ||
| CPH | CIPHER PHARMACEUTICALS INC | 20.52 | 427.232M | ||
| NGEN | NERVGEN PHARMA CORP | N/A | 402.7M | ||
| TSND | TERRASCEND CORP | N/A | 345.979M | ||
| HITI | HIGH TIDE INC | 24.63 | 298.826M | ||
| OGI | ORGANIGRAM GLOBAL INC | 28.6 | 263.504M | ||
| RX | BIOSYENT INC | 17.69 | 180.236M |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Toronto Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
About ACB.CA
Company Profile
Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. The company is headquartered in Leduc, Alberta and currently employs 1,101 full-time employees. The company went IPO on 2007-09-26. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company’s segments include Cannabis and Plant Propagation. The firm's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. The firm also holds a 50.1% controlling interest in Bevo Farms Ltd., a supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.
Company Info
IPO: 2007-09-26
AURORA CANNABIS INC
2207 90B Street Sw
Leduc ALBERTA T9E 0V6 CA
CEO: Miguel Martin
Employees: 1073
Phone: 16043625207
AURORA CANNABIS INC / ACB.CA FAQ
Can you describe the business of AURORA CANNABIS INC?
Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. The company is headquartered in Leduc, Alberta and currently employs 1,101 full-time employees. The company went IPO on 2007-09-26. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company’s segments include Cannabis and Plant Propagation. The firm's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. The firm also holds a 50.1% controlling interest in Bevo Farms Ltd., a supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.
What is the stock price of AURORA CANNABIS INC today?
The current stock price of ACB.CA is 4.7 CAD. The price decreased by -1.88% in the last trading session.
Does ACB stock pay dividends?
ACB.CA does not pay a dividend.
What is the ChartMill rating of AURORA CANNABIS INC stock?
ACB.CA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Where is AURORA CANNABIS INC (ACB.CA) stock traded?
ACB.CA stock is listed on the Toronto Stock Exchange exchange.
What is the analyst forecast for ACB.CA stock?
10 analysts have analysed ACB.CA and the average price target is 7.17 CAD. This implies a price increase of 52.46% is expected in the next year compared to the current price of 4.7.